Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

SU5416 and Doxorubicin in Treating Patients With Stage IIIB or Stage IV Inflammatory Breast Cancer

This study has been completed.
National Cancer Institute (NCI)
Information provided by:
Case Comprehensive Cancer Center Identifier:
First received: June 2, 2000
Last updated: June 10, 2010
Last verified: June 2010
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2003
  Primary Completion Date: December 2002 (Final data collection date for primary outcome measure)